Company Encyclopedia
View More
name
Outset Medical
OM.US
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd.
1.407 T
OM.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Health Care EquipmentIndustry
Industry Ranking88/171
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreE
    • ROE-94.23%E
    • Profit Margin-73.12%E
    • Gross Margin39.38%B
  • Growth ScoreC
    • Revenue YoY4.65%C
    • Net Profit YoY37.70%B
    • Total Assets YoY-5.34%D
    • Net Assets YoY197.70%A
  • Cash ScoreC
    • Cash Flow Margin-136.75%D
    • OCF YoY4.65%C
  • Operating ScoreC
    • Turnover0.42C
  • Debt ScoreC
    • Gearing Ratio48.65%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Dir Drexler Sells 1,548 ($6.8K) Of Outset Medical Inc [OM]

    Drexler Karen Director of Outset Medical Inc [OM] filed a Form 4 on December 2, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:Date12/1/25TransactionSaleShares1,548Price$4.37Value$6,765Ending Holdings: 12,733 (10,650 - Direct, 2,083 - Indirect) For a free trial, or to learn more about our insider trading analysis and data services, please visit or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.

    Reuters·
    US
    OM
    +9.51%
    Reuters·
    US
    OM
    +9.51%

    Director Karen Drexler Reports Sale of Outset Medical Inc. Common Shares

    Karen Drexler, Director at Outset Medical Inc., reported a sale of common shares of the company. The full filing is available via EDGAR, the U.S. SEC's system.

    Reuters·
    US
    OM
    +9.51%
    Reuters·
    US
    OM
    +9.51%

    15:03 ET INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of PetMed Express, Inc. (NASDAQ: PETS) and Encourages Investors with Substantial Losses to Contact the Firm

    Edelson Lechtzin LLP is investigating PetMed Express, Inc. for potential violations of federal securities laws due to alleged misleading business information. The investigation follows PetMed's delayed financial reports and significant stock price declines. Investors with substantial losses are encouraged to contact the firm. PetMed's stock dropped significantly after announcements of delayed financial results and internal reviews. Edelson Lechtzin LLP specializes in class action lawsuits involving securities and investment fraud.

    prnewswire·
    US
    PETS
    -1.70%
    prnewswire·
    US
    PETS
    -1.70%

    VP Nash Files To Sell 247 Of Outset Medical Inc [OM]

    Nash Marc, Vice President of Outset Medical Inc, filed a Form 144 with the SEC to sell 247 restricted shares on November 17, 2025. The sale will be conducted through Morgan Stanley Smith Barney LLC. Filing Form 144 is a prerequisite for selling restricted stock, allowing the sale within 90 days of filing.

    Reuters·
    US
    OM
    +9.51%
    US
    MS
    +0.67%
    Reuters·
    US
    OM
    +9.51%
    US
    MS
    +0.67%

    Officer Brottem Files To Sell 388 Of Outset Medical Inc [OM]

    Officer John L. Brottem of Outset Medical Inc filed a Form 144 with the SEC to sell 388 restricted shares on November 17, 2025. The sale will be brokered by Morgan Stanley Smith Barney LLC. Form 144 allows the sale of restricted stock within 90 days of filing. The Washington Service offers insider trading analysis and data services.

    Reuters·
    US
    OM
    +9.51%
    Reuters·
    US
    OM
    +9.51%
    © 2025 Longbridge｜Disclaimer